| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 763275 | (E)-8-(4-chlorobenzylidene)-4-(4-chlorophenyl)-3,4,5,6,7,8-hexahydroquinazolin-2-amine | 0.0342636096654276 | 0.09873567 |
| NSC 135687 | 5.beta.-Bufa-20,22-dienolide, 14,15.beta.-epoxy-3.beta.,5-dihydroxy-, 3-acetate (8CI) | 0.0385613993886001 | 0.25308368 |
| NSC 163424 | 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- | 0.0385613993886001 | 0.45392786 |
| NSC 173552 | L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate | 0.0385613993886001 | 0.44717076 |
| NSC 18805 | .gamma.-Thujaplicine | 0.0385613993886001 | 0.26047548 |
| NSC 258168 | 2,6-Pyridinedicarbonitrile, 3,4,5-tris(phenylthio)- | 0.0385613993886001 | 0.22319691 |
| NSC 267713 | Digitoxigenin glycoside | 0.0385613993886001 | 0.30416693 |
| NSC 275647 | 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- | 0.0385613993886001 | 0.45395663 |
| NSC 281818 | Ethanol, 2,2'-[[3-methyl-4-[[[4-[2-(4-propoxyphenyl]-4-thiazolyl]phenyl]imino]methyl]phenyl]imino]bis-, dimethanesulfonate (ester) | 0.0385613993886001 | 0.33163205 |
| NSC 332488 | 1,2,4-Triazolidine-3,5-dione, 1,2,4-tris(oxiranylmethyl)- | 0.0385613993886001 | 0.3382292 |